These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10923530

  • 1. [The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension].
    Lin J, Chen D, Wu K.
    Zhonghua Yi Xue Za Zhi; 1998 Mar; 78(3):200-2. PubMed ID: 10923530
    [Abstract] [Full Text] [Related]

  • 2. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G, Italian Study Group on Nilvadipine in Mild to Moderate Hypertension.
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [Abstract] [Full Text] [Related]

  • 3. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE.
    J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
    Kalina Z, Okopień B, Madej A, Tokarz D, Maślankiewicz A, Szwed Z, Gross-Furek V, Herman ZS.
    Boll Chim Farm; 1998 Nov; 137(7):281-5. PubMed ID: 9795483
    [Abstract] [Full Text] [Related]

  • 5. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.
    Curr Med Res Opin; 2003 Nov; 19(3):226-37. PubMed ID: 12803737
    [Abstract] [Full Text] [Related]

  • 6. Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial).
    Ryuzaki M, Nakamoto H, Nishida E, Sone M, Nakajima S, Yoshimoto M, Suzuki Y, Itagaki K.
    J Hypertens; 2007 Nov; 25(11):2352-8. PubMed ID: 17921832
    [Abstract] [Full Text] [Related]

  • 7. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 8. [Greater reduction of urinary albumin excretion in hypertensive patients with perindopril than nifedipine].
    Lin J, Chen D, Wu K.
    Zhonghua Nei Ke Za Zhi; 1999 May; 38(5):299-301. PubMed ID: 11798658
    [Abstract] [Full Text] [Related]

  • 9. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]

  • 10. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 11. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I, Saruta T, ADVANCE-Combi Study Group.
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [Abstract] [Full Text] [Related]

  • 12. Using administrative data to compare the relative effectiveness of amlodipine vs nifedipine CC.
    Lenert LA, Linde-Zwirble W, Newbold R, Korenblat BM, Doherty J, Smith ME.
    Am J Manag Care; 1999 Dec; 5(12):1535-40. PubMed ID: 11066620
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S, Maki K, Aota Y, Sakuma T, Iwasaka T.
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [Abstract] [Full Text] [Related]

  • 14. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
    Barrios V, Escobar C, de la Figuera M, Llisterri JL, Honorato J, Segura J, Calderón A.
    Cardiovasc Ther; 2008 Aug; 26(1):2-9. PubMed ID: 18466416
    [Abstract] [Full Text] [Related]

  • 15. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
    Uchida K, Azukizawa S, Kigoshi T, Nakano S, Kaneko M, Morimoto S, Matsui A.
    Clin Ther; 1994 Aug; 16(3):466-70. PubMed ID: 7923313
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 17. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
    Martínez Martín FJ.
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):863-9. PubMed ID: 19589122
    [Abstract] [Full Text] [Related]

  • 18. Double-blind comparison between nifedipine and amlodipine for the treatment of essential hypertension.
    Cappuccio FP, Markandu ND, Singer DR, Crane M, Carney C, MacGregor GA.
    J Hum Hypertens; 1993 Aug; 7(4):365-8. PubMed ID: 8410927
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE, Reyes AP, Wurdeman RL, Faulkner M.
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [Abstract] [Full Text] [Related]

  • 20. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension.
    Watanabe S, Okura T, Kurata M, Irita J, Manabe S, Miyoshi K, Fukuoka T, Murakami K, Higaki J.
    Clin Ther; 2006 Oct; 28(10):1677-85. PubMed ID: 17157123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.